Literature DB >> 28224396

Sacral Neuromodulation Implant Infection: Risk Factors and Prevention.

Calvin Lee1, Javier Pizarro-Berdichevsky2,3,4, Marisa M Clifton2, Sandip P Vasavada5,6.   

Abstract

Device infection is one of the most common complications of sacral nerve stimulator placement and occurs in approximately 3-10% of cases. Infection is a serious complication, as it often requires complete explantation of the device. Not much is known regarding risk factors for and methods of preventing infection in sacral nerve stimulation. Multiple risk factors have been linked to device infection including prolonged percutaneous testing and choice of preoperative antibiotic. Methods of infection prevention have also been studied recently, including antibiotic-impregnated collage and type of skin preparation. This review will discuss the recent literature identifying risk factors and means of preventing infection in sacral nerve stimulation. Finally, we will outline a protocol we have enacted at our institution which has resulted in an incidence of infection of 1.6%.

Entities:  

Keywords:  Device infection; Infection; Infection prevention; Sacral nerve stimulation; Sacral neuromodulation

Mesh:

Substances:

Year:  2017        PMID: 28224396     DOI: 10.1007/s11934-017-0663-1

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  21 in total

1.  Bacterial colonization of stimulation electrode wires in patients undergoing temporary sacral nerve stimulation.

Authors:  T Dudding; C Vaizey
Journal:  Colorectal Dis       Date:  2009-08-17       Impact factor: 3.788

2.  Prolonged percutaneous SNM testing does not cause infection-related explanation.

Authors:  Bastian Amend; Jens Bedke; Mahmoud Khalil; Arnulf Stenzl; Karl-Dietrich Sievert
Journal:  BJU Int       Date:  2012-06-28       Impact factor: 5.588

3.  Local administration of antibiotics by gentamicin-collagen sponge does not improve wound healing or reduce recurrence rate after pilonidal excision with primary suture: a prospective randomized controlled trial.

Authors:  Roland E Andersson; Gudrun Lukas; Stefan Skullman; Anders Hugander
Journal:  World J Surg       Date:  2010-12       Impact factor: 3.352

4.  Long-term efficacy and safety of sacral nerve stimulation for fecal incontinence.

Authors:  Anders Mellgren; Steven D Wexner; John A Coller; Ghislain Devroede; Darin R Lerew; Robert D Madoff; Tracy Hull
Journal:  Dis Colon Rectum       Date:  2011-09       Impact factor: 4.585

5.  Does Preadmission Cutaneous Chlorhexidine Preparation Reduce Surgical Site Infections After Total Hip Arthroplasty?

Authors:  Bhaveen H Kapadia; Julio J Jauregui; Daniel P Murray; Michael A Mont
Journal:  Clin Orthop Relat Res       Date:  2016-07       Impact factor: 4.176

6.  Use of a gentamicin-impregnated collagen sheet (Collatamp(®) ) following implantation of a sacral nerve stimulator for faecal incontinence.

Authors:  J A D Simpson; J Peacock; C Maxwell-Armstrong
Journal:  Colorectal Dis       Date:  2012-04       Impact factor: 3.788

7.  Characteristics of infections in patients undergoing staged implantation for sacral nerve stimulation.

Authors:  Michael L Guralnick; Saraleen Benouni; R Corey O'Connor; Charles Edmiston
Journal:  Urology       Date:  2007-06       Impact factor: 2.649

8.  Troubleshooting sacral neuromodulation issues.

Authors:  Maude E Carmel; Sandip P Vasavada; Howard B Goldman
Journal:  Curr Urol Rep       Date:  2012-10       Impact factor: 3.092

9.  Microbiological tined-lead examination: does prolonged sacral neuromodulation testing induce infection?

Authors:  Mirjam Huwyler; Gustav Kiss; Fiona C Burkhard; Helmut Madersbacher; Thomas M Kessler
Journal:  BJU Int       Date:  2009-03-13       Impact factor: 5.588

10.  Bacterial colonization rate of InterStim and infection outcome with staged testing.

Authors:  H Henry Lai; Shaun Grewal
Journal:  Urology       Date:  2013-10-16       Impact factor: 2.649

View more
  2 in total

1.  Comparison of efficacy and safety between electroacupuncture at 'four sacral points' and conventional electroacupuncture for the treatment of urinary incontinence after stroke: study protocol for a randomised controlled trial.

Authors:  Shan Chen; Siyou Wang; Lihua Xuan; Hanti Lu; Zhikai Hu; Chao Zhang; Huifang Zhang
Journal:  BMJ Open       Date:  2018-11-05       Impact factor: 2.692

2.  Bilateral electrical pudendal nerve stimulation as additional therapy for lower urinary tract dysfunction when stage II sacral neuromodulator fails: a case report.

Authors:  Shan Chen; Siyou Wang; Yunqiu Gao; Xiaolian Lu; Jiasheng Yan; Lihua Xuan; Shenhong Wang
Journal:  BMC Urol       Date:  2021-03-10       Impact factor: 2.264

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.